New online program aims to cut teen migraines in half
NCT ID NCT04567355
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an online program called Migraine Manager for teens aged 11 to 17 with frequent migraines (8 or more per month). The tool gives personalized tips on healthy habits like drinking water, eating regularly, exercising, and sleeping well. Researchers will compare 80 teens using the tool to 80 teens in a control group to see if it reduces headache days over a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Migraine Manager (online behavioral intervention)
- What this could lead to
- If it works, this could provide a simple, accessible online tool to help teens manage migraines and reduce headache frequency.
- What could go wrong
- This is a mid-stage trial with 160 participants, so results may not apply to all teens. The intervention relies on self-reported habits, which may not be accurate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Can a targeted botox shot quiet the Brain's pain center for chronic migraine?
- Could a symptom registry unmask hidden migraine variants?
- Melatonin may double up against childhood migraines
- A migraine-blocking antibody tested in children as young as 6